Lovro Kramer
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
-
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses
Papers in
-
- Protease and Inhibitor Mechanisms 3
-
- T-cell and B-cell Immunology 2
- Immunotherapy and Immune Responses 2
- Co-authors
- Boris Turk (5 shared papers)Vito Türk (2 shared papers)Marija Vukomanović (2 shared papers)Mario Kurtjak (2 shared papers)Danilo Suvorov (2 shared papers)Olga S. Vasiljeva (2 shared papers)Matej Vizovišek (1 shared paper)Hai‐Yu Hu (1 shared paper)
- Journals
- Journal of Clinical Investigation (1 paper)Molecular Therapy — Methods & Clinical Development (1 paper)Biotechnology Journal (1 paper)Frontiers in Immunology (1 paper)Frontiers in Bioengineering and Biotechnology (1 paper)
- Partner nations
- SloveniaSwitzerlandNetherlands
In The Last Decade
Lovro Kramer
13 papers receiving 472 citations
Peers
Comparison fields: 5 of 60
- Cancer Research 164
- Immunology 75
- Oncology 65
- Biomaterials 22
- Biomedical Engineering 66
Countries citing papers authored by Lovro Kramer
This map shows the geographic impact of Lovro Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lovro Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lovro Kramer more than expected).
Fields of papers citing papers by Lovro Kramer
This network shows the impact of papers produced by Lovro Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lovro Kramer. The network helps show where Lovro Kramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Lovro Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 160 | |
| 2 | 2014 | 61 | |
| 3 | 2020 | 60 | |
| 4 | 2016 | 56 | |
| 5 | 2017 | 44 | |
| 6 | 2016 | 35 | |
| 7 | 2019 | 35 | |
| 8 | 2019 | 18 | |
| 9 | 2021 | 5 | |
| 10 | 2023 | 4 | |
| 11 | 2022 | 3 | |
| 12 | 2024 | 1 | |
| 13 | 2025 | 1 | |
| 14 | 2026 | 0 |
About Lovro Kramer
Lovro Kramer is a scholar working on Cancer Research, Immunology, Oncology, Biomaterials and Molecular Biology, having authored 14 papers that have together received 483 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (3 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), CAR-T cell therapy research (3 papers), T-cell and B-cell Immunology (2 papers), Immunotherapy and Immune Responses (2 papers), Virus-based gene therapy research (1 paper), Nanoparticle-Based Drug Delivery (1 paper) and Bone Tissue Engineering Materials (1 paper). The work is most often cited by research in Cancer Research (164 citations), Immunology (75 citations), Oncology (65 citations), Biomaterials (22 citations) and Biomedical Engineering (66 citations). Lovro Kramer has collaborated with scholars based in Slovenia, Switzerland and Netherlands. Frequent co-authors include Boris Turk, Vito Türk, Marija Vukomanović, Mario Kurtjak, Danilo Suvorov, Olga S. Vasiljeva, Matej Vizovišek, Hai‐Yu Hu, K. Ulrich Wendt and Andraž Krajnc. Their work appears in journals such as Journal of Clinical Investigation, Molecular Therapy — Methods & Clinical Development, Biotechnology Journal, Frontiers in Immunology and Frontiers in Bioengineering and Biotechnology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.